







SURESH PATANKAR, ARVIND MUJUMDAR 
ACE Hospital & Research Centre, 32/2a, Erandwana. Pune 411004 
Email: Researchamai@Gmail.Com  
Received: 03 Sep 2014 Revised and Accepted: 05 Oct 2014 
ABSTRACT  
Objective: To study Acute, sub-acute oral toxicity profile of Herbmed plus (HP) - A herbal formulation. 
Methods: HP was derived from Crataeva nurvala Buch - Ham (Varun) bark, Musa paradisiaca Linn (Kadali/Banana) stem and roots, Achyranthes 
aspera Linn (Aghada) whole plant and Hordeum vulgare Linn (Yav) seeds. Above materials were converted into Varun bhavit kadali bhavit, kshars of 
Kadali, Aghada and Yav respectively and were mixed in certain proportions in GMP certified manufacturing facility to formulate HP capsules form. 
Acute and sub-acute safety profiles of HP was studied by OECD guidelines Number 423 and FDA guidelines in Swiss albino mice and Wistar rats 
respectively. For the acute study, HP was administered orally in a single dose of 2000mg/kg and for sub-acute study HP was administered orally 
using 90,180 and 450 mg/kg doses for 90 days.  
Results: In an acute study there were no behavioral changes and mortality at 2000 mg/kg by the oral route in mice up to 14 days. In sub-acute 
study after administration of various doses of HP for 90 days to various groups; there was no significant difference in body weight, food 
consumption, hematology / enzyme profiles, relative organ weights and histological observations of vital organs in comparison to control animals. 
Conclusion: The acute LD50 cut off for HP was found to be > 2000mg/kg in mice and No Observed Adverse Effect Level (NOAEL) for HP was found 
to be > 450 mg/kg by oral route for 90 days in Wistar rats.  
Keywords: Herbmed plus, Safety profiles in animals, Swiss albino mice, Wistar rats, OECD and FDA guidelines. 
 
INTRODUCTION 
For the medical management of Urolithiasis, the surgical procedures 
are considered as treatment of choice due to development of advanced 
techniques [1]. In the traditional system of medicine number of herbs 
and their formulations are prescribed and used empirically for the 
treatment of Urolithiasis. However, majority of them are not evaluated 
systematically by using acceptable guidelines for their safety, efficacy, 
indications and limitations. Earlier, we have developed, a herbal 
formulation ‘Herbmed’ derived from bark of Crataeva nurvala Buch-
Ham commonly known as Varun in vernacular and Kadali / banana 
roots, stem of Musa paradisiaca Linn based on traditional knowledge 
from Ayurved for the urinary tract disorders in general and for the 
treatment of Urolithiasis in particular [2-4]. This formulation was 
clinically evaluated in the prospective, randomized clinical studies 
which revealed promising activity for the management of upper 
urinary tract calculi, with reduction in pain, especially for renal calculi 
by reducing the size of calculi and facilitating their passage [5]. This 
formulation was modified to HP by supplementing with Achyranthes 
aspera Linn (Aghada) whole plant and seeds of Hordeum vulgare Linn 
(Yav). Based on traditional knowledge from Ayurved above plant 
materials were converted into Varun bhavit kadali bhavit, Kshars of 
Kadali, Aghada and Yav respectively [6] and formulated in certain 
proportion at GMP certified facility in capsule form. As per the Reverse 
Pharmacology principle it is the prerequisite to ensure safety of the 
formulation, hence, in the present communication preclinical acute 
and sub-acute safety profiles of HP were investigated in laboratory 
animals and the results of these studies are reported. 
MATERIALS AND METHODS 
Preparation of HP 
The bark of Crataeva nurvala Buch- Ham (Varun), stem and roots of 
Musa paradisiaca Linn (Kadali/Banana), Achyranthes aspera Linn 
(Aghada) whole plant and seeds of Hordeum vulgare Linn (Yav) were 
procured and authenticated at Agharkar Research Institute, Pune. 
These materials were converted into Varun bhavit Kadali bhavit, 
kadali kshar, Aghada kshar and Yav kshar respectively using typical 
Ayurvedic protocols [7,8] at Vishvaranga Ayurved Pharmacy, Pune: 
which is a GMP certified organization having FDA Maharashtra state 
approval. These materials were ensured for safety parameters at 
Charak Testing Laboratory, Mumbai for heavy metals (Pb, As, Hg, 
Cd) and Microbial count (Total aerobic count, Yeast, Mould and 
pathogenic bacteria count) following Ayurvedic pharmacopeia [9] 
for determination of their limits.  
Animals 
Female Swiss albino mice of 18-22 g and Wistar rats of mean 
weight139-178 g of either sex were used for these studies. They 
were housed in the CPCSEA approved animal house facility of 
National Toxicological Centre, Pune (NTC). They were housed in 
polypropylene cages in an air-conditioned area at 22±2 0C and 12 
hours light and dark cycle. They were provided with pellets of 
balanced animal food of Amrut brand of Nav Maharashatra Oil Mills, 
Pune and water was provided ad libitum. The experimental 
protocols were approved by the Institutional Animal Ethics 
Committee of the NTC, Pune. 
Methods  
Acute oral toxicity study 
The study was conducted in female Swiss albino mice using OECD 
guidelines Number 423 [10]. The animals were deprived of food for 
3-4 hours before and two hours after administration of HP and 
water was provided ad libitum. Based on exploratory studies and 
directives in respective OECD guidelines, as per the limit dose 
protocol HP was administered orally in a dose of 2000mg/kg in six 
animals for the final experiment. They were observed initially for 
four hours and subsequently, twice a day for 14 days for any 
behavioral changes or mortality if any. At the end of the study, 
necropsy observations of all animals were recorded.  
Sub acute toxicity study 
This study was conducted using Wistar rats; 24 males and 24 
females. They were divided into 4 equal groups, control and three 
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treatment groups. The treatment groups were given low, 
intermediate and higher oral doses of HP; 90, 180 and 450 
mg/kg/day respectively for 90 days based on exploratory studies. 
Initially all the animals were observed continuously for four hours 
and monitored daily at least once for their health status and signs of 
any abnormalities and morbid condition or death, if any. The body 
weight and food intake of the rats was determined once every week. 
At the end of the experimental period, blood samples were 
withdrawn from the retro-orbital plexus. Blood and serum samples 
were used for determination of various hematological and 
biochemical parameters. The hematological parameters were Hb, 
PCV and PT, in addition to Erythrocytes, Leucocytes count as well as 
differential count by a fully automated blood cell counter ERMA PCE-
210. The serum was separated from the blood by centrifugation and 
stored at −20°C for analysis of biochemical parameters viz., Glucose, 
SGPT, BUN, ALP using a semi automatic clinical chemistry analyzer 
AGD 400. The rats were mildly anaesthetized under pentobarbitone 
and sacrificed by cervical dislocation for necropsy observations of 
vital organs like liver, kidneys, lungs, spleen, adrenals, heart and 
ovaries/testis were dissected to determine their weights. They were  
expressed as relative % weight in g. kidneys, lungs, heart, 
testis/ovaries were preserved in 10% formalin solution. 
Subsequently, they were embedded in paraffin. They were sectioned 
and stained with hematoxylin and eosin to examine under 
microscope for histological observations.  
Statistical analysis 
All the results were expressed as Mean ± SD. The statistical analysis 
was carried out by using Prism card software.  
The treatment group animals were compared with control using one 
way analysis of variance (ANOVA) and the results were express as 
statistically significant for value p<0.05 
RESULTS AND DISCUSSION 
Acute oral toxicity study 
In acute toxicity study all the experimental animals well tolerated 
the dose of 2000 mg/kg of HP by oral route. They appeared normal 
and showed no abnormal clinical signs or symptoms and necropsy 
observations in comparison to control animals, with no mortality till 
14 days as per OECD guidelines No 423.  
Thus, according to the Global Harmonized Classification System 
(GHS) the LD50 cut off for HP was found to be > 2000 mg/kg body 
weight, which is GHS category- 5.  
Sub acute toxicity study 
In sub acute toxicity studies all rats appeared normal, without 
showing any signs or symptoms of abnormality in comparison to 
control animals at various doses like 90,180 and 450 mg/kg of HP by 
oral route of administration for 90 days. Usually alteration in the 
body weight is considered as an important parameter for the 
assessment of response of individual to the drugs [11] and may also 
indicates its side effects [12]. In the present study there was no 
significant change in body weight as well as food consumption in 
male and female rats in treatment group as compared to the 
respective control animals as shown in fig. 1 and 2. 
  
 
Fig. 1: Effect of treatment of various doses of HP for 90 days on Mean Body Weights 
 
          
Fig. 2: Effect of various doses of HP for 90 days on Mean Food consumption 
 
After the administration of various doses of HP to rats, there was no 
statistically significant effect on different hematological parameters like 
Erythrocytes, Leucocytes count and differential count, as well as, Hb, PCV 
PT in comparison to respective control animals as shown in Table1.
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Table 1: Effect of HP treatment on Hematological parameters in Male / Female rats 
Group Hb (g/dl) PCV 
% 
PT Sec Erythrocytes  
(x 10⁶/ mm³)  
Leucocytes  
(x 10³/mm³)  



























































































































































































































Note: No statistical difference observed in control and treatment groups. 
 
While conducting sub-acute study, the hematological observation is 
a direct reflection of the possible tissue injury caused by the test 
material under consideration. Blood biochemistry parameters 
constitute sensitive parameters of toxicity evaluation. For instance, 
changes in blood enzymes may be due to cellular/tissue injury 
leading to their systemic leakage from intracellular sites or target 
tissues [13]. As far as various blood chemistry parameters like, 
SGPT, BUN, ALP and total proteins were not significantly altered due 
to various doses of HP up to 450 mg/kg as compared to respective 
control group of animals as shown in Table 2. 
  
Table 2: Effect of HP treatment on blood chemistry parameters in Male/ Female rats 












































































































































Note: No statistical difference observed in control and treatment groups. 
 
In addition, repeated administration of HP did not affect the plasma 
glucose levels as compared to control group animals, which indicate 
that the HP did not affect carbohydrate metabolism or blood glucose 
regulation system. While evaluating sub-acute toxicity profile of any 
formulation in animals, at the termination of the study usually 
absolute as well as relative weight of vital organs are determined. 
These are indicative for the changes resulted in the functioning of 
various vital organs due to metabolic changes, secretion of 
enzymes/hormones leading to hyper/ hypoplasia and possible 
necrosis of tissue architecture [14]. In the present sub-acute study at 
termination the weights of vital organs like adrenals, heart, kidneys, 
liver, spleen, lungs, testis/ ovaries were determined and were 
converted into relative % organ weight and these were compared 
with control rats as shown in table 3. There was no significant 
change in the weights of vital organs of various treatment groups 
and control animals, indicating no significant effect on vital organs 
due to treatment of HP orally for 90 days at maximum dose up to 
450 mg/kg.  
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Table 3: Mean relative% organ weight data in g after HP Treatment in Male/Female rats 









































































































































































Note: No statistical difference observed in control and treatment groups. 
 
In gross necropsy observations there was no difference in control 
and HP treatment groups. Moreover, there were no histo 
pathological changes observed in sections of heart, liver, kidneys, 
testis/ovaries in HP treatment animals as compared to control 
group. This is in consistent with observations recorded in blood 
chemistry parameters like SGPT, BUN, ALP, etc. Thus, in sub acute 
treatment with 90 mg/kg, 180 mg/kg and 450 mg/kg of HP for 90 days 
to various groups of rats, showed no significant effect on body weight, 
food consumption, hematological as well liver enzyme profiles, relative 
organ weight and histological observations of vital organs in comparison 
to control animals. The NOAEL for HP was found to be > 450 mg/kg by 
oral route for 90 days in Wistar  rats. 
CONCLUSION 
The acute oral LD50 study cut off for HP by employing OECD 
guidelines in Swiss albino mice was found to be > 2000 mg/kg body 
weight after observing for 14 days. The sub acute oral treatment 
with 90 mg/kg, 180 mg/kg and 450 mg/kg of HP for 90 days to 
various groups of rats, showed no mortality no mortality and 
behavioral changes, no alteration in blood profile, biochemistry 
parameters and vital organs profiles in comparison to control 
animals. Thus, NOAEL for HP was found to be > 450 mg/kg by oral 
route for 90 days in Male and Female Wistar rats. 
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